loading...

Contact| FAQ
Submit a request

Chronic Treatment Acceptance Questionnaire (ACCEPT)

Mapi

Distributed by Mapi Research Trust

ProQolid

Distributed by Mapi Research Trust

Basic description

Developed in 2008

WEBINAR: An Author Webinar on the Chronic Treatment Acceptance Questionnaire - Recorded session available here!

Authors

Mapi

Copyright
ACCEPT© Mapi, 2011. All rights reserved.
Objective
The ACCEPT© questionnaire is a generic medication acceptance measure assessing how patients weigh advantages and disadvantages of long-term medications. ACCEPT© may be a predictor of patients' future adherence to and/or persistence with their treatment.
Therapeutic area
  • Generic
Therapeutic indication

All

Chronic diseases requiring long-term medications
Type of Clinical Outcome Assessment (COA)
  • pro PRO
Original language(s)
  • French for France
Bibliographic reference(s) of the original questionnaire

Arnould B, Gauchoux R, Meunier J, Gilet H, Regnault A. Validation of ACCEPT, a new generic measure to assess how patients with chronic diseases balance between the advantages and disadvantages of following the recommended treatment regimen in real-life. ISPOR 16th Annual European Congress, Dublin, Ireland, November 2013

Marant C, Longin J, Gauchoux R, Arnould B, Spizak C, Marrel A, Patrick DL, Van Ganse E. Long-term treatment acceptance: what is it, and how can it be assessed? Patient. 2012;5(4):239-49 (PubMed Abstract)

Chretin S, Viala-Danten M, Van Ganse E, Patrick D, Arnould B, Longin J. The missing piece between treatment experience and intention to persist: testing the internal consistency reliability and predictive validity of acceptability.  ISPOR 13th Annual European Congress, Prague, Czech Republic, November 2010

Marant C, Longin J, Spizak C, Patrick D, Saussier C, Arnould B, Van Ganse E. What does acceptability mean for patients and how should it be measured? Qualitative steps for the development of a new measurement instrument for pharmacies: the “ACCEPT©” questionnaire. ISPOR 11th Annual European Congress, Athens, Greece, November 2008

Access this questionnaire

Ask Formal Written Permission

Users are first required to obtain written permission to use the ACCEPT from the author before filling out a license agreement with Mapi Research Trust.

All requests have to be submitted through our online request management:

  1. Log in or Register for free
  2. Submit your request (Tutorials are available on our FAQs)
  3. Our PROVIDE team will get back to you with the needed information and license agreement in a timely manner
Submit a Request

Contact and conditions of use

Authors

Mapi

Benoit Arnould
Mapi
27 rue de la Villette
69003 Lyon
France
Email: Benoit.Arnould@iconplc.com

Contact information

Mapi Research Trust
PROVIDE™
27 rue de la Villette
69003 Lyon
France
Phone: +33 (0)4 72 13 66 66

Conditions of use

Ask Formal Written Permission

Users are first required to obtain written permission to use the ACCEPT from the author before filling out a license agreement with Mapi Research Trust.

All requests have to be submitted through our online request management:

  1. Log in or Register for free
  2. Submit your request (Tutorials are available on our FAQs)
  3. Our PROVIDE team will get back to you with the needed information and license agreement in a timely manner

Author Website(s)

Webpage dedicated to the ACCEPT

Review copy

Examination copies can only be used for the limited purpose of examining the suitability of the Questionnaire for subsequent research and/or clinical use, and cannot be used in research or in clinical practice or distributed to others.
You are not authorized to modify, retype, translate, copy or otherwise duplicate the Questionnaire except with the further and prior written permission of Mapi Research Trust / the developers / copyright holders / distributors.

Languages

Original language(s)

  • French for France

Translations

The listed translations may not have undergone a full linguistic validation process and may require further work to be suitable for use in a study. This list is subject to constant changes, therefore please check the status of translations with Mapi Research Trust / the developers / copyright holders / distributors.

ACCEPT

Afrikaans for South Africa*
Dutch for the Netherlands*
English for Australia*
English for Canada*
English for South Africa*
English for the UK*
English for the USA*
French for Canada*
French for Switzerland*
German for Germany*
German for Switzerland*
Italian for Italy*
Japanese for Japan*
Korean for South Korea*
Polish for Poland*
Portuguese for Brazil*
Russian for Russia*
Slovak for Slovakia*
Sotho for South Africa*
Spanish for Argentina*
Spanish for Colombia*
Spanish for Mexico*
Spanish for Spain*
Spanish for the USA*
Swedish for Sweden*
Turkish for Turkey
Xhosa for South Africa*
Zulu for South Africa*
* Performed by Mapi

The author has selected Mapi/ICON Language Services as exclusive linguistic validation company to ensure the production of harmonized and consistent language versions.

For additional information on available translations of this instrument, or for a project involving new languages, please submit a request (tutorials available on our FAQs).

Conditions to translate

Academic Translation

If you wish to translate the questionnaire:

  1. Log in or Register for free
  2. Submit your request for translation online (Tutorials are available on our FAQs)
  3. Our PROVIDE team will send you a translation agreement along with Linguistic Validation Guidelines.

Commercial Users

Exclusive vendor for translation work for commercial users: Mapi/ICON Language Services

Member Access

Subscribe to PROQOLID to access to full information

Access to advanced descriptions of Clinical Outcome Assessments (COAs)

MORE INFORMATION Subscribe NOW
A question? Contact us